Table 1 Prevalence of anti-HCV and HBsAg in the screened population stratified by gender
From: Mass screening for hepatitis B and C in Southern Upper Egypt
Positive | Negative | Total | Prevalence (%) | |
|---|---|---|---|---|
Anti-HCV Abs | ||||
Female | 3413 | 31,664 | 35,077 | 9.73 |
Male | 6288 | 25,677 | 31,965 | 19.67 |
Total | 9701 | 57,341 | 67,042 | 14.47 |
ORa for Male = 2.27; 95% CI 2.2–2.4 | ||||
HBsAg | ||||
Female | 965 | 34,097 | 35,062 | 2.75 |
Male | 1982 | 29,963 | 31,945 | 6.20 |
Total | 2947 | 64,060 | 67,007 | 4.40 |
OR for Male = 2.34; 95% CI 2.2–2.5 | ||||
Anti-HCV & HBsAg | ||||
Female | 24 | 35,038 | 35,062 | 0.07 |
Male | 83 | 31,862 | 31,945 | 0.26 |
Total | 107 | 66,900 | 67,007 | 0.16 |
OR for Male = 3.8; 95% CI 2.4–5.99 | ||||